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Abstract: 
Introduction:  
Dementia is a major public health issue both in the United States and worldwide. Alzheimer’s disease 
(AD) is widely considered to be the most prevalent type of dementia. While the hallmark AD symptom is 
profound memory loss, patients also commonly experience changes in personality and behavior. These 
changes often include depression, anxiety, social withdrawal, mood swings, irritability and aggression, 
changes in sleeping habits, and delusions.  
Background:  
Several studies have established a mechanistic link between traumatic brain injury (TBI) and the 
development of AD. However, it is unknown whether TBI contributes to the personality/behavior changes 
observed in many AD patients. The current study examined a possible association between TBI and 
psychiatric conditions in patients who present with clinically diagnosed dementia due to AD. 
Methods:  
Participants in the current study were sampled from the National Alzheimer’s Coordinating Center 
dataset. Only participants who had AD at the time of their most recent assessment were included in the 
study (N=10,511). Logistic regression was used to analyze the association between TBI and adverse 
psychiatric outcomes (defined as presence of psychosis or agitation/aggression) in patients with AD. 
Confounding variables, including age, gender, education, and dementia severity, were included in final 
regression models. 
Results: 
Agitation/Aggression: 
This study found an association with alcohol abuse (OR: 1.87), age group of 65-74 (OR: 1.41), and 
having active diabetes in both the mild (OR: 1.21) and moderate (OR: 1.25) states of AD. A remote 
history of seizure in moderate AD had one of the strongest associations with increased odds of 
agitation/aggression (OR: 2.24). In those with severe AD and agitation/aggression, a protective 
association was found in those age 85+ (OR: 0.66), and in those with a recent history of urinary 
incontinence (OR: 0.59). 
Psychosis: 
The lowest educational attainment group had the highest risk of developing psychosis, with mild AD & 0-
12 years of education (OR: 1.67), those with moderate AD & 0-12 years of education (OR: 1.76), in those 
with moderate AD & 13-16 years of education (OR: 1.53). At a mild stage of AD there was a suggestive 
association with urinary incontinence (OR: 1.20). In addition, being age 85+ at a severe stage of AD had a 
suggestive protective association (OR: 0.67). 
Conclusion: 
No significant association was found between TBI and psychiatric symptoms in persons with AD. 
However, there was evidence of an association between age, diabetes, alcohol abuse, urinary incontinence 
and seizures with agitation/aggression. Age, education level, and a recent history of incontinence are 
associated with increased odds of developing psychosis.
		
Introduction: 
Dementia is a major public health issue not only in the United States but also worldwide. 
While there are several types of dementia, Alzheimer’s disease (AD) is generally considered to 
be the most prevalent.1 The Diagnostic and Statistical Manual of Mental (DSM) Disorders V 
classifies AD into two categories: major neurocognitive disorder (ND) and mild neurocognitive 
disorder.2 These two categories can be further subdivided into probable and possible cases. A 
probable diagnosis of AD is assigned – either through genetic testing or familial history – based 
on evidence of the AD genetic mutation.2 In addition, a probable case must have a clear 
presentation of memory decline and decline of at least one other cognitive function. A possible 
diagnosis of AD is given when there is no evidence of an AD genetic mutation but there is clear 
evidence of memory and information retention issues as well as steady cognitive decline without 
extended plateaus.2 Both possible and probable diagnoses must present without evidence of 
mixed etiology.2 While this is how AD is classified by the DSM-V, it is important to note that 
this is only one form of diagnostic classification. There are several methods that clinicians use to 
diagnose AD. Some of these methods include a thorough medical history, mental status testing, 
physical and neurological exams, imaging scans, and blood tests to rule out other types of 
dementia.3  
Traditionally, the hallmark AD symptom is memory loss. However, people with AD also 
commonly experience disorientation; difficulty with spatial relationships, speaking and writing, 
judgment, planning, and/or carrying out familiar tasks; and changes in personality and behavior. 
These behavior and personality changes are generally characterized by symptoms such as 
depression, anxiety, social withdrawal, mood swings, distrust, irritability and aggression, 
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changes in sleeping habits, wandering, loss of inhibition, and delusions.1 Memories established 
early in life are often the last to be lost during the course of the disease.1  
AD places a heavy cognitive disease burden on the U.S. population, with 60-90% of all 
dementia cases being attributed to AD.2 The overall prevalence of dementia increases with age.2 
Of the people diagnosed with AD, 7% are between the ages of 65 and 74, 53% are between the 
ages of 75 and 84, and 40% are 85+ years old.2 In 2013, as defined by the ICD-9, AD was one of 
the 15 leading causes of death in the U.S.4 In 2013, there were 84,767 total deaths attributed to 
AD.4,5 Mortality increased from 1999 to 2013,4 with the majority of deaths occurring between the 
ages of 75 and 84; for people older than 85 there was an increase in mortality rates until 2008.4 
Mortality in the 75-84 age range has begun to decline; in 1999, the mortality rate of AD was 
129.5 deaths per 100,000 people, with the rate peaking in 2008 at 192.5 deaths per 100,000 
people and later declining to 171.6 deaths per 100,000 people in 2013.4 Additionally, deaths 
among those older than age 85 have begun to decrease, with the all-time highest death rate to 
date occurring in 2008 at 1,002.2 deaths per 100,000 people.4 By 2013, this rate had decreased to 
929.5 deaths per 100,000 people.4 The age-adjusted rate increased from 16.5 deaths per 100,000 
people in 1999 to 25.8 deaths per 100,000 people in 2008, with a slight decrease between 2008 
and 2013 to 23.5 deaths per 100,000 people.4  
Although there does not appear to be any single definitive cause of AD, it is generally 
agreed that several risk factors contribute to the development of disease.1 Genetic and 
physiological risk factors for AD include age, genetic susceptibility (apolipoprotein E4 or 
APOE), Down’s syndrome, vascular problems, and environmental risk factors, including 
traumatic brain injuries (TBI).2 Upon autopsy, individuals with AD often show evidence of 
cortical atrophy and high levels of amyloid-predominant neuritic plaques and/or tau-predominant 
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neurofibrillary tangles.2 These plaques and tangles are thought to contribute to brain shrinkage 
through neuron death, which causes many of the symptoms of AD.6 
The purpose of this study was to assess the potential link between TBI history and 
psychiatric conditions in patients who present with medically diagnosed dementia due to AD. It 
evaluated the association between AD-related psychiatric symptoms or diagnosed psychiatric 
illnesses and reported TBIs.  
Literature Review: 
This literature review was conducted using PubMed, an online repository of medical and 
health-related peer-reviewed journals articles maintained by the National Institutes of Health. 
The main key words employed in the literature review were: Alzheimer’s disease, psychiatric 
conditions, traumatic brain injuries, dementia, increased risk, risk factors, and increased odds. 
A TBI is the loss or alteration of consciousness, with or without prograde and retrograde 
amnesia, that involves immediate physical and neurological symptoms ranging from mild to 
severe.7 TBIs can cause several types of chronic physical, cognitive, and behavioral issues. The 
most common form of brain injury is an acute mild TBI or concussion.7 Several epidemiological 
studies have tried to establish a mechanistic link between a TBI as an exposure and the 
development of AD as an outcome. These studies have produced conflicting results. Both a study 
in Japan by Kondo et al. and a study in Kentucky by Abner et al. found an increased risk of 
developing AD to be associated with a history of head injury, though results varied slightly 
between studies.8,9 Using a case control study to examine risk factors for AD, Kondo et al. found 
that a head injury with a loss of consciousness (LOC) increased the odds of developing AD 5.5 
times as compared with having no history of head injury with a LOC (p<0.001).8 Abner et al. 
found that the odds of developing dementia among those with a history of TBI was only 
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significantly increased in males (OR 1.47, 95% CI 1.03 to 2.09); and the odds of developing AD 
in women with a history of TBI was increased but not found to be statistically significant (OR 
1.18, 95% CI 0.83 to 1.68).9 Two studies, the Rotterdam study and the Adult Changes in 
Thought study found that there was no statistically significant association between the 
development of AD and having a history of head injury.9 Plassman et al. had a mixed result with 
increased rates in those with moderate (HR=2.32, p-value<0.05) and severe head injury 
(HR=4.51, p-value<0.05), however decreased risk in those with mild head injuries (HR=0.76, p-
value>0.05), though the latter was not found to be statistically significant.12 
Hyperphosphorylated tau, the main component in neurofibrillary tangles, is one of the 
pathological hallmarks of AD. Higher levels of tau are found in those who died with AD than in 
those who did not. A study by Jeromin et al. found that soldiers with a self-reported history of 
TBI had higher blood levels of Tau than those who had not experienced a TBI (p=0.03).13 While 
an elevated tau level is expected in individuals with TBI, it was initially believed that these 
levels only remained high for a few hours immediately following the injury.13 However, the 
study by Jeromin et al. indicated that these levels remained elevated for up to 3-18 months.13 
This study also found that the severity of total post-concussive symptoms was significantly 
correlated with total Tau concentrations in those with self-reported TBI (p=0.003).13 
Furthermore, the study indicated that people who suffered multiple TBIs maintained long-term 
elevated tau levels. The level of measured tau was directly correlated with the severity of 
symptoms experienced. The long-term health effects of elevated tau levels are currently 
unknown, but it is possible that elevated tau levels could be associated with a history of TBI and 
increased risk of AD, as elevated tau is thought to be one of the risk factors in AD development. 
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However, a major limitation to this study is that it does not report whether the Tau measured was 
the phosphorylated Tau found in neurofibrillary tangles.  
Another study used mice with AD as a model and induced TBIs to observe the resulting 
changes in behavior. This study specifically examined how ß-amyloid (the main component in 
neuritic plaques) contributes to the neuro-inflammatory response post-concussive injury.2,14 This 
study showed a difference in the recovery of mice with higher levels of ß-amyloid as compared 
with mice with lower levels of ß-amyloid.14 This finding suggests a possible correlation between 
TBIs and AD-associated outcomes. Although there is some research on this connection between 
TBIs and AD outcomes, further analysis would help improve prediction of negative health 
outcomes for AD sufferers.  
AD, an already burdensome disease, becomes more difficult to manage when the patient 
also suffers from neuropsychiatric symptoms (NPS).15 Some studies have found that those with 
AD who suffer from NPS will have an expedited decline, both functionally and cognitively.16,17 
They also have been known to have a lower quality of life, often with earlier institutionalization 
and accelerated mortality rates.18-22 Those who suffer from delusions or agitation had an 
increased risk of being institutionalized as compared to those who did not have delusions or 
agitation, with a hazard ratio of 5.74 (95% CI: 1.94-16.96) and 4.70 (95% CI: 1.07-20.70), 
respectively.22 The presence of overwhelmed caregivers was often found to be a main mediating 
variable for institutionalization in those with delusions and or agitation.22 Those suffering from 
hallucinations were found to have an increased mortality rate: HR=2.59 (95% CI: 1.09-6.16).22 
Some studies have found that NPS are predictors for the future onset of dementia in those with 
mild cognitive impairment (MCI).23 A longitudinal study of a cohort who presented with MCI at 
the time of study found that those who had NPS were at an increased risk of developing AD: 
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HR=1.35 (95% CI: 1.09-1.66).23 Due their close linkage with adverse health events and 
decreased quality of life of those with AD, NPS have been shown to be important targets for 
prevention.15 Currently, most research on the association between NPS and AD conceptualizes 
NPS as a predictor of AD. Limited research has explored the risk factors for those who have AD 
and subsequently develop NPS.  
Psychosis, defined as suffering from hallucinations and delusions, is a common 
occurrence in patients with AD, with one study reporting a prevalence of 41%.24 Psychosis rates 
in patients with AD have been shown to be higher in those who reside in nursing facilities, with 
more than 66% suffering with symptoms for a time period longer than 10 weeks.24 Imaging 
studies indicate that NPS symptoms can be caused by the neurodegeneration of areas associated 
with these psychiatric symptoms.24 Single photon emission tomography (SPECT) scans have 
shown that patients suffering with dementia and psychosis usually manifest with preferential 
involvement of the frontal lobe and/or the limbic regions, as well as hypoperfusion in the parietal 
lobe.24 There also tended to be gender differences when examining perfusion positron emission 
tomography (PET) scans, with females having lower perfusion in the right inferior-lateral frontal 
cortex and inferior temporal regions as compared to those who were not psychotic and males 
having higher perfusion in the right striatum.24 SPECT scans also have shown decreased blood 
flow to the frontal and temporal regions of the brain in those suffering with agitation.24  
However, research has shown that neuropathological explanations are not sufficient to 
explain why NPS happen in those with AD.24 It is likely that a combination of factors (e.g., 
environmental, biological abnormalities, psychiatric history, family history, genetic 
susceptibility) contribute to NPS.24 Neuropathological studies on psychosis have shown an 
increased deposition of neuritic plaques and neurofibrillary tangles in the areas associated with 
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varying psychotic symptoms when patients with AD are autopsied.24 In a prospective 
clinicopathologic study, those who had AD confirmed by autopsy were found to have less severe 
neuron loss in the parahippocampal gyrus and non-significant lower neuron numbers in the 
serotonergic dorsal raphe nucleus than patients who had no NPS symptoms.25  
Studies have shown concussions, or TBIs, to be linked not only with cognitive 
impairment but also with psychiatric symptoms. Sports-related head injuries have been 
demonstrated to be highly associated with MCI and depression in retired football players.26 A 
prospective longitudinal study that examined symptoms and recovery time in those who suffered 
from a mild TBI found that a subset population of people with persistent symptoms post-injury 
suffered from psychological symptoms such as depression, traumatic stress, and low resilience.27 
A cross-sectional study on collegiate athletes concluded that athletes with a history of concussion 
displayed changes in their frontal-alpha and frontal-beta asymmetry by an electro 
encephalogram, which are indicative of increased general mood disturbances when compared to 
the controls (p < 0.05).28 These findings also were correlated with self-reported depression and 
anxiety in those who suffered from frontal-alpha asymmetry and self-reported anger/aggression 
in those with alterations in beta-asymmetry.28 However, these correlations were found to be 
significant only in the athletes who had a history of concussion.28 
While the current literature address NPS and their effects in people with AD on multiple 
levels, continued research is needed on NPS predictive risk factors. This would aid in a holistic 
understanding of the potential causes and risk factors for these symptoms in those with dementia 
due to AD. In addition, this would aid in a more personalized approach in symptom prevention 
and management, as well as aid in the enhancement of quality of life.  
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Methods: 
Study Design and Data 
This study used a cross-sectional design to examine whether those with AD and a history 
of TBI had increased odds of NPS, primarily psychosis and agitation/aggression. These two 
conditions were chosen because they often are the primary psychiatric conditions that cause a 
person with AD to enter into early institutionalization.15  
Data for this project were obtained from the National Alzheimer’s Coordinating Center 
(NACC) Uniform Data Set and Neuropathology databases (December 2014 freeze) with full 
neuropsychiatric inventory. Dr. Erin Abner of the University of Kentucky’s College of Public 
Health and Sanders-Brown Center on Aging submitted the data request on December 7, 2015, 
with approval granted the same day. Data then were downloaded from the NACC’s online portal. 
Data in this study are representative of Version 1 & 2 of the protocols conducted by the NACC. 
The NACC Uniform Dataset consists of annual examinations of study participants, or by a co-
participant (usually a family member or close friend), at each of the ~30 federally funded 
Alzheimer’s Disease Centers (ADCs). All locations have different qualifying criteria for 
participation in the study. Participants may have any cognitive status. The total number of 
assessments included in the original data set amounted to 103,710, with 105 variables.  Each 
individual participant could have multiple data lines due to annual follow-up visits to assess 
cognitive function. All research activities were approved by an Institutional Review Board (IRB) 
at the research center at which the participant was recruited and followed. All subjects provided 
written informed consent. No IRB approval was needed for this secondary analysis of the de-
identified NACC data. 
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Variable Selection 
Data for the current study were limited to the most recent clinical assessment available. 
Participants were limited to those with a clinical diagnosis of AD dementia at the last assessment 
(N=10,511).  Variables of interest were retained, and several new variables were generated, 
including dementia due to AD, categorical educational attainment, categorical age groups, 
presence of agitation/aggression, psychosis, and TBI, and a new variable for race that collapsed 
Asian and Pacific Islander categories due to low numbers. TBI was defined as the participant 
having indicated that during their lifetime they had suffered from a recent (current) or remote 
(historically far-off) head injury, which had resulted in a brief loss of consciousness (LOC), an 
extended LOC, or a chronic deficit. All those who indicated no to the three types of head injury 
reported on were coded as having no history of TBI. In contrast, those who answered yes to one 
or multiple types were coded as having a history of TBI. Levels of education were categorized as 
0-12 years (12=High School Diploma), 13-16 years (16=Bachelors Degree), 17-18 years 
(18=Masters Degree), and 18< years (18+ =Doctoral Degree). These ranges were chosen to 
reflect common U.S. educational attainment levels. In addition, the age groups were categorized 
as <65, 65-74, 75-84, and 85+ because these are the same groupings used by the CDC to report 
incidence and prevalence rates of AD in the U.S. The remaining variables then were assessed for 
missing-ness using frequency counts. Variables of interest included: AD status; AD severity; 
TBI status; psychosis status; agitation/aggression status; medical history related to incontinence, 
stroke, seizure, bypass, hypertension, heart attack, use of psychiatric drugs, smoking status, and 
alcohol or non-prescription drug use/abuse; and demographics such as age, gender, race, and 
years of educational attainment. No variable of interest had greater than a 15% missing rate, thus 
all variables were included in the analysis.  
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Statistical Analysis 
Logistic regression, with dependent variables of agitation/aggression and psychosis, was 
used to estimate odds ratios for risk factors of interest. Initially, a bivariate analysis of each 
variable of interest was conducted for both dependent variables. Using the outcomes of these 
bivariate analyses, a complete model was generated. The model was further refined using 
backwards elimination to establish which variables should be kept in the final regression model. 
Based on these results, history of heart disease, history of cardiac bypass, and history of 
hypertension were eliminated from the model. Diabetes, history of drug abuse, and history of 
alcohol abuse were retained in the model, despite backwards elimination indicating they may not 
be necessary. This decision was made because diabetes, drug use, and alcohol abuse have a close 
relationship with an outcome of interest (agitation/aggression). Models were run with 
educational attainment and age as both categorical and continuous variables. Both education and 
age had higher significance levels when modeled as categorical rather than continuous variables; 
therefore, these two variables were run categorically. The final models then were run using 
selected variables. Due to wide confidence intervals, a secondary analysis of the model was 
conducted to identify unnecessary variables. This secondary analysis suggested that smoking 
status, prescription psychiatric drug use, gender, and race should be removed from the model in 
an effort to increase power. Akaike’s Information Criterion was used to compare the models. 
Due to minimal change in these numbers as well as minimal changes in confidence intervals, 
these variables were excluded from the final model. Each model then was stratified by AD 
severity, which is associated with prevalence of NPS, using the Clinical Dementia Rating Global 
(CDRGLOB) score, ranging from 1 to 3 (1=mild dementia, 2=moderate dementia, 3=severe 
dementia), to generate six separate outputs. Additional variables were created for TBI, psychosis, 
and agitation/aggression to represent at which visit each participant was diagnosed with 
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psychosis, agitation/aggression, and/or TBI. The frequency of each was calculated to ensure that 
the majority of TBIs occurred at or before the diagnosis of psychological symptoms, which 
helped to ensure that exposure preceded the onset or diagnosis of psychological disorders.  
 
Results: 
Table 1.1 is a summary of participant demographics. The participants were 43.7% male 
and 56.3% female. In addition, those with TBI tended to be, at 60% to 40% female. The number 
of participants was highest in the age group of 75-84 years (41.5%) and lowest in the age group 
of less than 65 years (10.9%). While the percentage of people ages 75-84 is representative of the 
average percentage with AD in this age group, the number of participants in the age group of 65-
74 years is higher than average at 21.8%, and the age group of 85+ years is lower than average at 
only 25.8%.2 The percentage of white participants is high in this study, with 80.4% of the study 
participants identifying as white and only 11.6% identifying as black or African American, 0.7% 
as American Indian, 1.9% as Asian/Pacific Islander, and 3.2% as multiracial. Only 10.2% of 
study participants reported having suffered from a TBI. Of those that reported a TBI, the highest 
rate was in the participants who reported a TBI with a brief loss of consciousness (75.4%). 
Educational attainment was evenly distributed among those who had a high school education or 
less (38.0%) and those who had a college degree (37.4%). The proportion of substance abuse 
among those who had experienced a TBI was higher than among those who had not. Of those 
who had experienced a TBI, 11.0% reported abusing alcohol and 1.8% reported abusing drugs.  
 
Table 2.1-2.2 shows the bivariate, crude values of all variables that were ultimately 
included in the adjusted models. All results are presented in odds ratios and stratified by AD 
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severity (mild, moderate, and severe). In those with mild AD and agitation and aggression, there 
were significantly increased odds of being in the age group of 65-74 years (OR=1.42, p-
value=0.004) and having diabetes (OR=1.24, p-value=0.03), when compared to those age <65 
and those who never had diabetes. There also was a marginally significant between abuse of 
alcohol, both recent (OR=1.60, p-value=0.09) and remote (OR=1.30, p-value=0.07) when 
compared to those who had no history of alcohol abuse. In those with moderate AD and agitation 
and aggression, there were increased odds of having diabetes, when compared to those who had 
no diabetes (OR=1.26, p-value=0.05). Conversely, being in the age group of 85+ years had a 
protective effect (OR=0.75, p-value=0.04), when compared to those in age group <65. In those 
with severe AD and agitation and aggression, there was a decrease in odds of having a history of 
seizures both recent (OR=0.62, p-value=0.01) and remote (OR=0.64, p-value=0.05), and having 
urinary incontinence (OR=0.66, p-value=0.0002), using those with no history of seizures or 
urinary incontinence as a comparison group. In addition, there is a suggested association with 
those 85 and older (OR=0.75, p-value=0.07) using those in age group <65 as a control. 
In those with mild AD and psychosis, there were increased odds of having urinary 
incontinence (OR: 1.23, p-value=0.04), when compared to those with no history of urinary 
incontinence. Those with moderate AD had increased odds of being aged 65-74 (OR=1.38, p-
value=0.05), having 0-12 years of education (OR=1.38, p-value=0.001), and having 13-16 years 
of education (OR=1.25, p-value=0.01) when using those in age group <65 and educational 
attainment of 18+ years as controls. Having a remote history of urinary incontinence appears to 
have a protective affect (OR=0.65, p-value=0.07), when compared to those who had no history 
of incontinence in those with moderate AD. Those with severe AD had increased odds of having 
0-12 years of education (OR=1.58, p-value=0.01), diabetes (OR=1.38, p-value=0.02), and a 
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suggested association with alcohol abuse (OR=6.66, p-value=0.09) using 18+ years of education, 
no history of diabetes, and no history of alcohol abuse as comparison groups. 
Tables 3.1 presents the association between agitation and aggression and TBI, stratified 
by severity of Alzheimer’s disease as mild, moderate, and severe. Those with mild AD and 
agitation/aggression had an increased odds of being in age group 65-74 (OR=1.41, p-
value=0.007) when compared to those in age group <65, and those with recent alcohol abuse, 
using those with no history of alcohol abuse for comparison (OR=1.87, p-value=0.04). There 
was also a suggestive association in this group with those who had a recent history of diabetes 
compared to those with no diabetes, with increased odds of 21% (OR=1.21, p-value=0.07). In 
those with moderate AD and agitation/aggression, there was a suggestive association between 
diabetes (OR=1.25, p-value=0.08), a remote history of seizures (OR=2.24, p-value=0.05), and 
remote urinary incontinence (OR=1.18, p-value=0.08), when compared to those who had no 
history of those conditions. In those with severe impairment due to AD, both those in age group 
85+ (OR=0.66, p-value=0.07) and a recent history of seizures (OR=0.59, p-value=0.03) appeared 
to have a protective association with agitation/aggression, when compared to those who were in 
age group <65 and had no history of seizures. 
Table 3.2 evaluates the association between psychosis and TBI, stratified by the severity 
of AD (mild, moderate, and severe). In this adjusted model, those with mild AD and psychosis 
had an increased odds of being having and educational attainment of only 0-12 years (OR=1.67, 
p-value=0.001) and recent urinary incontinence (OR=1.20, p-value=0.09), as compared to those 
who had 18+ years of education and no urinary incontinence. While urinary incontinence was 
not statistically significant, there was a suggestive association. Those with moderate AD and 
psychosis had increased odds of being in age group 65-74, when compared to those who were 
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<65 years, with a 45% increased odds (OR=1.45, p-value=0.03). In addition those with moderate 
AD and psychosis had and increased odds of having only 0-12 and 13-16 years of educational 
years, 76% increased odds (p-value=0.001) and 53% increased odds (p-value=0.01), 
respectively. In those with severe AD and psychosis ages 85+ appeared to have a suggestive 
protective association, with an OR of 0.67 (p-value=0.07) when compared to those <65 years of 
age.  
Discussion: 
The purpose of this study was to assess whether TBI was a potential risk factor for psychiatric 
symptoms in AD patients. There does not appear to be any significant association between TBI 
and agitation/aggression at any level of AD severity. However, there are several covariates that 
appeared to be significantly associated with agitation/aggression. It should be noted that while an 
association was not found with TBI, this study had a pervasive statistical power issue, increasing 
the probability of a Type II error—failure to find an association when one actually exists.  
 When AD was mild, there was a strong association with alcohol abuse and 
agitation/aggression symptoms. However, this association disappeared as the severity of the AD 
increased from moderate to severe. This result could occur because as the severity of AD 
increases, the likelihood of a person having access to substances, or the faculties to maintain an 
addiction, likely decrease. In contrast to those still actively abusing alcohol, as it is known that a 
symptom of alcohol abuse is mood instability, and therefore it is likely that the abuse of alcohol 
itself could be the cause of the agitation/aggression symptoms.  
 Those with mild AD also had increased odds in being in the age group 65-74; this could be 
because people of this age are entering a time where independence post retirement becomes 
important. However, with a diagnosis of AD, a person might feel they are losing their gained 
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independence faster than those others of their age group. In addition, a loss of cognitive function 
can be a big lifestyle change, causing anger and aggression. Another reason this age group could 
be experiencing higher agitation/aggression could be the lack of properly trained elder care 
workers working with those at this level of AD.  
 There also was an association between having active diabetes and having 
agitation/aggression in both the mild and moderate states of AD. One explanation of this 
association could be that when diabetes is not managed appropriately, diabetic shock may cause 
mood instability, which could be misdiagnosed as a neuropsychiatric symptom caused by AD. 
Though this association was not statistically significant, it could be a clinically significant 
association.  
 A remote history of seizure with AD had one of the strongest associations with an odds 
ratio of 2.24 for agitation/aggression, in those with moderate AD compared to those who did not 
have a history of seizures. An explanation of this association could be that if seizures are severe 
enough, it can cause brain damage affecting the centers of the brain responsible for agitation and 
aggression symptoms. However, without more informed medical history on the severity of 
seizures this association cannot be explored.  
 In those with severe AD and agitation/aggression, a protective association was found in 
those age 85+ and in those with a recent history of urinary incontinence. This is likely due to the 
fact that old age, urinary incontinence, and severe AD are all likely factors to cause 
institutionalization; therefore they are likely receiving superior medical care as well as be highly 
medicated to control their symptoms. 
Psychosis was not significantly associated with TBI. In addition, those in the lowest 
educational attainment group had the highest risk of developing psychosis, with 67% increased 
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odds in people who had mild AD and 0-12 years of education, 76% increase in odds in people 
who had moderate AD and 0-12 years of education, and 53% increase in odds in those who had 
13-16 years of education. These findings could be attributed to the protective effect of education 
and cognitive reserve, indicated by several studies; the higher the level of educational attainment, 
the more protective cognitive reserve appears to be.30  
At a mild stage of AD there is suggestive association between urinary incontinence and 
having psychosis, with an increased odds of 20%. While not statistically significant, the p-values 
were relatively close to 0.05. A study by Choudhury et al found that there was a statistically 
significant increase in odds of having urinary incontinence in those with psychosis, as compared 
to those who did not have psychosis, however it is important to note that no participants with 
dementia participated in this study.29 Lastly, it appears that being age 85+ at a severe stage of AD 
has a suggestive protective association in moderate AD. This result could be explained by an 
increase in care. As those who are older and at a more severe stage of AD are more likely to be 
institutionalized; therefore, it could be hypothesized that these individuals are receiving better 
care than those who are younger and not incontinent.  
Limitations 
This study had many limitations. One main limitation was a lack of statistical power, due 
to the small number of participants who reported a TBI (effect variable). There also was a large 
amount of information bias. While the data provides information on TBIs with LOC or chronic 
deficit, it does not record data on brain injuries without an LOC or TBIs that did not cause 
noticeable deficits. In addition to this limitation, once a TBI is recorded, NACC does not record 
the amount of TBIs each individual has incurred. This protocol could have led to an 
underreporting of the amount of TBIs that were actually experienced. In addition to a possible 
underreporting of TBIs, there also is no information on how each TBI was acquired. Loss to 
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follow-up with this particular population may have been a problem due to the fact that all 
participants are sampled at different times, leaving an incomplete picture of developed symptoms 
as participants progress into worsening AD.  
Selection bias also was problem, as a large proportion of people participating in the study 
were white and college-educated. Therefore, the study population is not representative of the 
overall population. Recall bias also could have played a role in this study, as information was not 
always ascertained from the original participant, with some information provided by a co-
participant. In addition, there is a testing bias regarding the participants’ TBI status because no 
medical confirmation of a TBI was required for version 1 and 2 of the NACC study, making it 
difficult to know whether participants had repeated head injury.  
Future Directions 
This study evaluated the association between several potential variables and 
psychological symptoms among AD patients. However, there are several directions that future 
studies could take to further the understanding of TBIs and NPS in people with AD. One area of 
importance would be examining the cellular and molecular changes that occur in patients who 
have had a TBI and exploring whether there is a difference in those who had the exposure and 
those who did not. The number of TBIs someone has experienced also is important, as this factor 
addresses whether there is a dose-response curve with the number of TBIs and the severity of 
symptoms experienced. A longitudinal prospective cohort study is also an area for future 
research, as this design would allow a time to event to be calculated. Lastly, a study that removes 
TBIs, which occurred after psychiatric symptoms started, could assess the time trend of the 
exposure (TBI) and the outcome (psychosis and agitation/aggression). For the purpose of this 
study, agitation and aggression were the only psychiatric symptoms analyzed, but an expansion 
of psychological symptoms experienced could reveal other important connections, as there are 
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many types of NPS that impact patients and caregivers. By expanding the types of symptoms 
analyzed, there is the potential to enhance the holistic understanding of the effect of TBIs on 
neuropsychological outcomes. 
Conclusion:  
This study did not find an association between TBI and psychiatric symptoms in persons 
with AD. However, there appears to be an association with age (65-74 years), active diabetes, 
active alcohol abuse, recent urinary incontinence, and a remote history of seizures and an 
increase in the odds of having agitation/aggression. However, those with severe AD and a recent 
history of seizures have decreased odds of developing agitation/aggression. In those with 
psychosis, education 0-12 years in patients with mild AD, and in those with moderate AD age 
65-74 years, education 0-12 years and 13-16 years, had increased odds of developing psychosis. 
The limitations of this study reduce its ability to accurately assess possible associations between 
TBI and psychiatric conditions in persons with AD.  
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Appendix 
 
 
Figure 1: Study participant breakdown 
 
 
 
All	Study	Particpants	N=103,710	
Participants	with	Alzheimer's	Disease	N=10,511	
History	of	Traumatic	Brain	Injury	N=1,072	
Agitation/Aggression		N=577	 Psychosis	N=280	 No	Agitation/Aggression	and	or	Psychosis	
No	History	of	Traumatic	Brain	Injury	N=9,439	
No	Agitation/Aggression	and	or	Psychosis	 Agitation/Aggression		N=4,819	 Psychosis	N=2,377	
Participants	without	Alzheimer's	Disease	N=93,199	
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Table 1.1: Study Population Demographics   
 
 TOTAL (N=10,511) 
n (%) 
TBI Positive (N=1,072) 
n (%)  
TBI Negative (N=9,439) 
n (%)  
Sex 
     Male 4, 596 (43.7) 646 (60.3) 3, 950 (41.8) 
     Female 5, 915 (56.3) 426 (39.7) 5, 489 (58.2) 
Age 
     <65 1, 143 (10.9) 158 (14.7) 985 (10.4) 
     65-74 2, 294 (21.8) 263 (24.5) 2, 031 (21.5) 
     75-84 43.62 (41.5) 382 (35.6) 3, 980 (42.2) 
     85+ 2, 712 (25.8) 269 (25.1) 2,443 (25.9) 
Race (NACCHIHR) 
     White 8, 451 (80.4) 926 (86.3) 7, 525 (79.7) 
     Black or African American 1, 223 (11.6) 71 (6.6) 1, 152 (1.6) 
     American Indian or  
     Alaska Native 
74 (0.7) 9 (0.8) 65 (0.7) 
     Asian/ Pacific Islander 199 (1.9) 10 (0.9) 189 (2.0) 
     Multiracial 337 (3.2) 39 (3.6) 298 (3.2) 
Years of Education 
      0-12 yrs  
     (12=High School Diploma) 
3, 997 (38.0) 355 (33.1) 3, 642 (38.6) 
     13-16 yrs 
     (16=Bachelors Degree) 
3, 935 (37.4) 415 (38.7) 3, 520 (37.3) 
     17-18 yrs 
     (18=Masters Degree) 
1, 497 (14.2) 174 (16.2) 1, 323 (14.0) 
     18< 
     (Doctoral Degree) 
1, 082 (10.3) 128 (11.9) 954 (10.1) 
TBI Exposure 
     Brief Loss of 
     Consciousness  
808 (7.7) 808 (75.4) -- 
     Extended Loss 
     Consciousness 
292 (2.8) 292 (27.2) -- 
     Chronic Deficit 66 (0.6) 66 (6.2) -- 
Alzheimer’s Disease Status 
     Mild (CDGLOB=1) 3,737 (35.6) 377 (35.2) 3, 360 (35.6) 
     Moderate (CDGLOB=2) 2,779 (26.4) 272 (25.4) 2, 507 (26.6) 
     Severe (CDGLOB=3) 2,103 (20.0) 222 (20.7) 1, 881 (19.9) 
Medical History 
     History of Stroke 760 (7.2) 77 (7.2) 683 (7.2) 
     Hypertension 5, 274 (50.2) 499 (46.5) 4, 775 (50.6) 
     Diabetes 1, 559 (14.8) 155 (14.5) 1, 404 (14.9) 
     Seizures 500 (4.8) 98 (9.1) 402 (4.3) 
     Urinary Incontinence 4, 029 (38.3) 471 (43.9) 3, 558 (37.7) 
Substance Abuse History 
     Alcohol Abuse 767 (7.3) 118 (11.0) 649 (6.9) 
     Drug Use 96 (0.9) 19 (1.8) 77 (0.8) 
Smoking Status 
     Ever Smoker 4, 552 (43.3) 534 (49.8) 4, 018 (42.6) 
     Never Smoked 5, 823 (55.4) 527 (49.2) 5, 296 (56.1) 
Psychological State 
     Agitation & Aggression 5, 396 (53.3) 577 (53.8) 4, 819 (51.1) 
     Psychosis 2, 657 (26.3) 280 (26.1) 2, 377 (25.2) 
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Table 2.1: Bivariate analysis of agitation and aggression by severity of Alzheimer’s disease. 
 
 
 
 
 AD with Mild Impairment 
CDRGLOB=1  
AD with Moderate Impairment 
CDRGLOB=2 
AD with Severe Impairment 
CDRGLOB=3 
  
N  
 
OR (95% CI) 
 
p-value 
 
N 
 
OR (95% CI) 
 
p-value 
 
N 
 
OR (95% CI) 
 
p-value 
Head Injury (TBI) Exposure  
     TBI Positive  191 1.06 (0.85-1.32) 0.59 169 1.21 (0.94-1.57) 0.15 124 1.07 (0.80-1.43) 0.67 
     No History of TBI  1678 -- -- 1472 -- -- 1000 -- -- 
Age  
     <65 196 -- -- 173 -- -- 133  -- -- 
     65-74 474 1.42 (1.12-1.81) 0.004 334 1.16 (0.87-1.56) 0.32 241  0.97 (0.69-1.36) 0.85 
     75-84 829 1.13 (0.91-1.41) 0.26 675 1.02 (0.78-1.33) 0.90 415 0.90 (0.66-1.22) 0.49 
     85+ 22.87 0.97 (0.76-1.23) 0.79 414 0.75 (0.57-0.99) 0.04 335  0.75 (0.55-1.03) 0.07 
Education   
     0-12 yrs 736 1.16 (0.92-1.46) 0.20 654 1.16 (0.88-1.52) 0.29 449 0.99 (0.71-1.38) 0.96 
     13-16 yrs 680 0.94 (0.74-1.18) 0.57 572 1.11 (0.84-1.46) 0.46 405 0.85 (0.61-1.18) 0.32 
     17-18 yrs 263 0.96 (0.74-1.26) 0.78 225 1.26 (0.91-1.74) 0.17 163 0.96 (0.66-1.40) 0.83 
     18+ yrs 190 -- -- 145 -- -- 107 -- -- 
Health Conditions  
     Diabetes (Recent) 270 1.24 (1.02-1.50) 0.03 227 1.26 (1.00-1.59) 0.05 157 1.11 (0.85-1.45) 0.44 
     Diabetes (Remote) 31 1.20 (0.71-2.04) 0.50 24 0.91 (0.49-1.67) 0.75 18 0.79 (0.40-1.54) 0.48 
     No Diabetes 1565 -- -- 1341 -- -- 945 -- -- 
     History of Stroke 1618 1.13 (0.87-1.47) 0.35 149 1.14 (0.87-1.50) 0.35 86 1.11 (0.75-1.63) 0.61 
     No History of Stroke 136 -- -- 1248 -- -- 613 -- -- 
     History of Seizures (Recent) 23 0.94 (0.53-1.68) 0.84 29  0.93 (0.53-1.62) 0.79 66 0.62 (0.440.87) 0.01 
     History of Seizures (Remote) 33  1.24 (0.74-2.10) 0.42 30  1.76 (0.90-3.44) 0.10 39  0.64 (0.41-1.00) 0.05 
     No History of Seizures 1,801  -- -- 1,532  -- -- 1,011 -- -- 
     Incontinence (Recent)* 389 1.07 (0.91-1.25) 0.44 593 1.05 (0.90-1.24) 0.53 802 0.66 (0.53-0.83) 0.0002 
     Incontinence (Remote)* 69 1.11 (0.80-1.55) 0.53 53 0.96 (0.63-1.47) 0.85 22 0.74 (0.38-1.44) 0.37 
     No Incontinence* 1394 -- -- 945 --  297 -- -- 
Substance Use  
     Alcohol Abuse (Recent) 35 1.60 (0.93-2.77) 0.09 13 1.14 (0.47-2.75) 0.78 3 1.11 (0.19-6.67) 0.91 
     Alcohol Abuse (Remote) 124 1.30 (0.98-1.71) 0.07 105 0.99 (0.73-1.35) 0.96 83 1.12 (0.79-1.59) 0.53 
     No Alcohol Abuse 1703 -- -- 1471 -- -- 1033 -- -- 
     Drug Abuse (Recent) 2 0.63 (0.10-3.74) 0.61 1 0.35 (0.03-3.87) 0.39 0 N/A N/A 
     Drug Abuse (Remote) 14 0.77 (0.38-1.57) 0.47 13 2.28 (0.74-6.99) 0.15 8 0.59 (0.23-1.489) 0.26 
     No Drug Abuse 1851 -- -- 1575 -- -- 1113 -- -- 
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Table 2.2: Bivariate analysis of psychosis by severity of Alzheimer’s disease. 	
 
 
 
 
 
 
AD with Mild Impairment 
CDRGLOB=1  
AD with Moderate Impairment 
CDRGLOB=2 
AD with Severe Impairment 
CDRGLOB=3 
  
N 
 
OR (95% CI) 
 
p-value 
 
N 
 
OR (95% CI) 
 
p-value 
 
N 
 
OR (95% CI) 
 
p-value 
Head Injury (TBI) Exposure  
     TBI Positive 74 0.97 (0.74-1.26) 0.80 103 1.15 (0.89-1.49) 0.30 86 1.17 (0.87-1.56) 0.31 
     No History of TBI  688 -- -- 860 -- -- 649 -- -- 
Age  
     <65 73 -- -- 93 -- -- 89 -- -- 
     65-74 175 1.22 (0.90-1.65) 0.20 208 1.38 (1.02-.86) 0.04 150 0.87 (0.62-1.22) 0.42 
     75-84 342 1.28 (0.96-1.69) 0.09 416 1.25 (0.95-.64) 0.12 289 0.99 (0.73-1.35) 0.96 
     85+ 172 1.19 (0.88-1.61) 0.26 246 0.97 (0.72-1.29) 0.81 207 0.73 (0.53-1.00) 0.05 
Education   
     0-12 yrs 341 1.70 (1.26-2.30) 0.0005 425 1.71 (1.26-2.30) 0.001 344 1.58 (1.13-2.22) 0.01 
     13-16 yrs 271 1.23 (0.91-1.66) 0.19 350 1.51 (1.11-2.04) 0.01 246 0.96 (0.68-1.36) 0.83 
     17-18 yrs 88 1.01 (0.71-1.44) 0.97 118 1.29 (0.91-1.83) 0.16 83 0.81 (0.54-1.20) 0.29 
     18+ yrs 62 -- -- 70 -- -- 62 -- -- 
Health Conditions  
     Diabetes (Recent) 113 1.18 (0.94-1.48) 0.16 810 1.14 (0.91-1.44) 0.26 116 1.38 (1.06-1.79) 0.02 
     Diabetes (Remote) 9 0.73 (0.36-1.50) 0.40 136 0.80 (0.42-1.54) 0.50 14 1.15 (0.58-2.29) 0.68 
     No Diabetes 638 -- -- 13 -- -- 603 -- -- 
     History of Stroke 55 1.06 (0.77-1.44) 0.73 85 0.98 (0.74-1.30) 0.89 58 0.98 (0.67-1.41) 0.89 
     No History of Stroke 664 -- -- 760 -- -- 434 -- -- 
     History of Seizures 
     (Recent) 
13  1.50 (0.78-2.86) 0.22 21  1.28 (0.73-2.25) 0.39 56  1.10  0.59 
     History of Seizures 
     (Remote) 
12  0.99 (0.52-1.88) 0.98 15  1.01 (0.54-1.92) 0.97 25  0.74 0.21 
     No History of Seizures 729  -- -- 923  -- -- 645  -- -- 
     Incontinence (Recent)* 177 1.23 (1.01-1.49) 0.04 366 1.07 (0.91-1.27) 0.39 535 0.85 (0.69-1.05) 0.14 
     Incontinence (Remote)* 24 0.75 (0.48-1.17) 0.21 24 0.65 (0.40-1.04) 0.07 14 0.85 (0.43-1.68) 0.63 
     No Incontinence* 557 -- -- 569 -- -- 186 -- -- 
Substance Use  
     Alcohol Abuse (Recent) 12 1.03 (0.54-1.97) 0.92 5 0.57 (0.21-1.56) 0.27 4 6.66 (0.74-59.65) 0.09 
     Alcohol Abuse (Remote) 49 1.11 (0.80-1.54) 0.53 63 0.99 (0.72-1.35) 0.93 53 1.04 (0.73-1.47) 0.83 
     No Alcohol Abuse 698 -- -- 888 -- -- 674 -- -- 
     Drug Abuse (Recent) 0 <0.001 (<0.001 
>999.999) 
0.96 1 0.91 (0.08- 10.08) 0.94 0 N/A N/A 
     Drug Abuse (Remote) 8 1.31 (0.58-2.94) 0.51 6 1.00 0.37-2.70) 0.99 7 1.05 (0.41-2.72) 0.92 
     No Drug Abuse 753 -- -- 949 -- -- 727 -- -- 
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Table 3.1: Multivariate analysis of agitation and aggression by severity of Alzheimer’s 
disease 
 
 
 AD with Mild Impairment 
CDRGLOB=1 
AD with Moderate Impairment 
CDRGLOB=2 
AD with Severe Impairment 
CDRGLOB=3 
  
OR (95% CI) 
 
p-value 
 
OR (95% CI) 
 
p-value 
 
OR (95% CI) 
 
p-value 
Head Injury (TBI) Exposure  
     TBI Positive 1.11 (0.89-1.41) 0.35 1.05 (0.78-1.42) 0.74 0.99 (0.64-1.54) 0.97 
     No History of TBI  -- -- -- -- -- -- 
Age  
     <65 -- -- -- -- -- -- 
     65-74 1.41 (1.10-1.81) 0.007 1.19 (0.87-1.84) 0.27 1.11 (0.68-1.80) 0.68 
     75-84 1.12 (0.89-1.41) 0.35 1.07 (0.80-1.43) 0.64 0.82 (0.53-1.27) 0.37 
     85+ 0.94 (0.73-1.21) 0.62 0.80 (0.59-1.09) 0.16 0.66 (0.42-1.04) 0.07 
Education   
     0-12 yrs 1.15 (0.90-1.46) 0.26 1.18 (0.87-1.59) 0.28 1.04 (0.63-1.69) 0.89 
     13-16 yrs 0.93 (0.73-1.18) 0.55 1.12 (0.83-1.52) 0.46 0.87 (0.53-1.42) 0.57 
     17-18 yrs 0.99 (0.75-1.01) 0.93 1.28 (0.90-1.84) 0.18 0.78 (0.44-1.39) 0.40 
     18+ yrs -- -- -- -- -- -- 
Health Conditions  
     Diabetes (Recent) 1.21 (0.99-1.49) 0.07 1.25 (0.97-1.61) 0.08 1.02 (0.72-1.46) 0.90 
     Diabetes (Remote) 1.08 (0.62-1.89) 0.78 0.99 (0.50-1.95) 0.98 0.87 (0.33-2.29) 0.77 
     No Diabetes -- -- -- -- -- -- 
     History of Stroke 1.19 (0.91-1.55) 0.20 1.20 (0.90-1.60) 0.20 1.30 (0.86-1.97) 0.21 
     No History of Stroke -- -- -- -- -- -- 
     History of Seizures (Recent) 1.02 (0.55-1.90) 0.94 0.89 (0.47-1.69) 0.72 0.59 (0.37-0.96) 0.03 
     History of Seizures (Remote) 1.52 (0.86-2.68) 0.15 2.24 (1.01-4.99) 0.05 0.74 (0.36-1.54) 0.42 
     No History of Seizures -- -- -- -- -- -- 
     Incontinence (Recent)* 1.06 (0.89-1.26) 0.55 1.18 (0.98-1.41) 0.08 0.88 (0.66-1.18) 0.38 
     Incontinence (Remote)* 1.15 (0.79-1.66) 0.47 1.04 (0.65-1.68) 0.87 0.68 (0.28-1.69) 0.41 
     No Incontinence* -- -- -- -- -- -- 
Substance Use  
     Alcohol Abuse (Recent) 1.87 (1.03-3.40) 0.04 1.45 (0.55-3.86) 0.45 0.73 (0.12-4.53) 0.73 
     Alcohol Abuse (Remote) 0.77 (0.36-1.65) 0.15 0.87 (0.62-1.23) 0.44 1.22 (0.71-2.09) 0.47 
     No Alcohol Abuse -- -- -- -- -- -- 
     Drug Abuse (Recent) 0.17 (.02-1.75) 0.14 0.85 (0.05-13.71) 0.91 NA NA 
     Drug Abuse (Remote) 0.77 (0.36-1.65) 0.50 1.99 (0.61-6.46) 0.25 0.46 (0.14-1.51) 0.20 
     No Drug Abuse  -- -- -- -- -- -- 
*Urinary Incontinence 
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Table 3.2: Multivariate analysis of psychosis by severity of Alzheimer’s disease. 
 
 AD with Mild Impairment 
CDRGLOB=1 
AD with Moderate Impairment 
CDRGLOB=2 
AD with Severe Impairment 
CDRGLOB=3 
  
OR (95% CI) 
 
p-value 
 
OR (95% CI) 
 
p-value 
 
OR (95% CI) 
 
p-value 
Head Injury (TBI) Exposure  
     TBI Positive 0.94 (0.71-1.26) 0.68 1.22 (0.90-1.65) 0.20 1.02 (0.67-1.55) 0.93 
     No History of TBI  -- -- -- -- -- -- 
Age  
     <65 -- -- -- -- -- -- 
     65-74 1.24 (0.90-1.71) 0.19 1.45 (1.04-2.02) 0.03 0.87 (0.55-1.37) 0.55 
     75-84 1.28 (0.95-1.72) 0.11 1.29 (0.95-1.76) 0.10 0.94 (0.62-1.43) 0.78 
     85+ 1.16 (0.83-1.61) 0.39 1.00 (0.72-1.38) 0.98 0.67 (0.43-1.04) 0.07 
Education   
     0-12 yrs 1.67 (1.22-2.28) 0.001 1.76 (1.27-2.45) 0.001 1.45 (0.91-2.31) 0.12 
     13-16 yrs 1.23 (0.90-1.69) 0.19 1.53 (1.10-2.13) 0.01 0.85 (0.53-1.36) 0.49 
     17-18 yrs 0.96 (0.66-1.40) 0.85 1.29 (0.88-1.91) 0.20 0.65 (0.37-1.14) 0.13 
     18+ yrs -- -- -- -- -- -- 
Health Conditions  
     Diabetes (Recent) 1.13 (0.89-1.43) 0.34 1.11 (0.86-1.42) 0.43 1.11 (0.79-1.56) 0.55 
     Diabetes (Remote) 0.77 (0.37-1.59) 0.47 0.89 (0.44-1.80) 0.74 0.96 (0.36-2.52) 0.93 
     No Diabetes -- -- -- -- -- -- 
     History of Stroke 1.01 (0.73-1.39) 0.95 0.94 (0.70-1.25) 0.49 0.98 (0.66-1.44) 0.90 
     No History of Stroke -- -- -- -- -- -- 
     History of Seizures (Recent) 1.153 (0.77-3.03) 0.22 1.38 (0.73-2.64) 0.32 1.47 (0.90-2.39) 0.12 
     History of Seizures (Remote) 1.20 (0.62-2.32) 0.59 1.21 (0.61-2.43) 0.58 0.63 (0.30-1.34) 0.23 
     No History of Seizures -- -- -- -- -- -- 
     Incontinence (Recent)* 1.20 (0.97-1.48) 0.09 1.14 (0.95-1.37) 0.17 0.91 (0.69-1.20) 0.50 
     Incontinence (Remote)* 0.75 (0.46-1.23) 0.26 0.65 (0.38-1.11) 0.11 1.30 (0.53-3.21) 0.57 
     No Incontinence* -- -- -- -- -- -- 
Substance Use  
     Alcohol Abuse (Recent) 1.09 (0.55-2.15) 0.81 0.46 (0.15-1.40) 0.17 4.93 (0.54-45.51) 0.16 
     Alcohol Abuse (Remote) 1.08 (0.76-1.54) 0.65 0.89 (0.63-1.28) 0.54 1.18 (0.72-1.96) 0.51 
     No Alcohol Abuse -- -- -- -- -- -- 
     Drug Abuse (Recent) <0.001 (<0.001- >999.999) 0.97 1.99 (0.12-32.03) 0.63 N/A N/A 
     Drug Abuse (Remote) 1.67 (0.72-3.90) 0.24 0.66 (0.20-2.14) 0.49 0.92 (0.28-2.99) 0.88 
     No Drug Abuse  -- -- -- -- -- -- 
*Urinary Incontinence 
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